Low dosage ciclosporin A in penetrating keratoplasty. A bicentric study of 90 cases;Traitement par ciclosporine A, a doses faibles, dans les keratoplasties transfixiantes a haut risque. Etude bicentrique de 90 cas

Journal Francais d'Ophtalmologie

Volumn 20, Issue 7, 1997, Pages 507-514

  Robert, P Y ^a   Delbosc, B ^b   Preux, P M ^a   Monnot, P H ^b   Drouet, M ^a   Peyronnet, P ^a   Adenis, J P ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Ciclosporin A; Immune reaction; Keratoplasty; Survival analysis

Indexed keywords

CYCLOSPORIN A;

ADULT; AGED; ALLOGRAFT; ARTICLE; CLINICAL ARTICLE; CORNEA TRANSPLANTATION; FEMALE; FOLLOW UP; HUMAN; MALE; PENETRATING KERATOPLASTY; PREDICTION; SURVIVAL;

CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREMEDICATION; RISK FACTORS;

EID: 0030809711     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. COSTER T.A., SHEPHERD W.F.I., CHIN FOOK T., RICE N.S.C., JONES B.R. - Prolonged survival of corneal allografts in rabbits treated with cyclosporin A. Lancet, 1979; 2:655-689.
2. SHEPHERD W.F.I., COSTER D.J., CHIN FOOK T., RICE N.S.C., JONES B.R. - Effect of cyclosporin a on the survival of corneal graft in rabbits. Br J Ophthalmol, 1980; 64:148-153.
3. SALISBURY J.D., GEBHARDT B.M. - Suppression of corneal allograft rejection by cyclosporin A. Arch Ophthalmol, 1981; 99:1640-1643.
4. HUNTER P.A., GARNER A., WILHELMUS K.R., RICE N.S.C., JONES B.R. - Corneal graft rejection : a new rabbit model and cyclosporin-A. Br J Ophthalmol, 1982; 66:292-302.
5. HILL J.C. - The use of systemic cyclosporin in a human corneal transplantation : a preliminary report. Doc Ophthalmol, 1986; 62:337-344.
6. BIALASIEWICZ A.A., NAUMANN G.O.H. - Systemische Zyklosporin-A-Therapie bei Risiko-Keratoplastik. Fortschr Ophthalmol, 1989; 86:574-580.
7. SUNDMACHER R. -Six years' experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients. A retrospective study. German J Ophthalmol, 1992; 1:432-436.
8. SUNDMACHER R., REINHARD T. - Cyclosporin A in high risk perforating keratoplasty. In : «Zieruth M. (ed.), Immunology of corneal transplantation». Aeolus Press, Buren, 1995; 233-238.
9. HILL J.C. - The use of cyclosporine in high-risk keratoplasty. Am J Ophthalmol, 1989; 107: 506-510.
10. HILL J.C. - Systemic cyclosporine in high-risk keratoplasty : short versus long-term therapy. Ophthalmology, 1994; 101:128-133.
11. ARNE J.L., LEGRAVE L., LESUEUR L., THOUVENIN D., BOURDIOL A.M. - Utilisation de la ciclosporine A par voie générale dans la prévention du rejet de greffe à risque. Ophtalmologie, 1993; 7:167-168.
12. VOLKER-DIEBEN H.J., D'AMARO J., VAN SLOOTEN H., KRUIT P.J. - The effect of cyclosporin A on corneal graft survival. In : « Zieruth M. (ed.), Immunology of corneal transplantation ». Aeolus Press, Buren, 1995; 239-246.